UBS Raises Oracle (ORCL) Price Target to $285, Citing Strong AI Momentum

UBS raised its price target on Oracle Corporation (NYSE: ORCL) to $285, citing sustained AI momentum heading into the company's upcoming earnings report. The revision reflects growing conviction among analysts that Oracle's AI-related business is holding up strongly. Shares of Oracle last traded at $233.49 on Wednesday, June 3, down $11.09 on the session.

What Changed

• New UBS price target: $285 per share, revised upward ahead of Oracle's next earnings report
• Analyst thesis: UBS sees AI momentum remaining strong as the primary driver of the target increase, according to the report cited by Yahoo Finance
• Analyst consensus: Oracle holds a Strong Buy or Buy rating from 40 of 49 analysts covering the stock as of June 1, 2026
• Hold ratings narrowed: The number of analysts rating the stock Hold dropped from 10 in May 2026 to 8 in June 2026, reflecting modestly improving sentiment
• 52-week context: Oracle shares have traded in a range of $134.57 to $345.72 over the past year, with the current price sitting well below the recent peak

Why It Matters

The UBS target revision signals that at least one major institutional research desk sees Oracle's AI integration strategy as durable rather than cyclical. According to Yahoo Finance reporting on the broader software sector, investors are increasingly differentiating between companies successfully embedding AI into their offerings and those still dependent on legacy subscription pricing — a distinction that appears to be informing UBS's positive reassessment of Oracle.

The timing ahead of Oracle's scheduled earnings report adds weight to the revision, as analysts typically update price targets when they have high conviction in near-term results. The breadth of bullish analyst coverage — with 40 of 49 tracked analysts at a Buy-equivalent rating — suggests UBS's view is far from an outlier on Wall Street.

Wall Street View

Analyst sentiment on Oracle has tightened in a bullish direction heading into June 2026. The latest consensus logged on June 1 shows 17 Strong Buy ratings, 23 Buy ratings, 8 Hold ratings, and just 1 Sell, with zero Strong Sell recommendations. That compares to 17 Strong Buy, 24 Buy, and 10 Hold ratings recorded in May — meaning two analysts shifted from Hold to a more constructive stance over the past month. The forward price-to-earnings ratio of 29.0x (TTM — may not reflect latest quarter) suggests the market is pricing in meaningful growth expectations that analysts like UBS appear to endorse.

Investor Takeaway

UBS's $285 price target represents meaningful upside from Oracle's current trading level of $233.49, and the firm's emphasis on AI momentum aligns with the dominant investment thesis driving software sector re-ratings in 2026. With 40 of 49 analysts at a Buy-equivalent rating and Hold counts shrinking, institutional conviction in Oracle's near-term trajectory appears to be building rather than fading. Investors will likely look to the company's next earnings report to validate whether the AI-driven growth narrative meets the bar Wall Street has now raised.